Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase NA 2Phase EARLY_PHASE1 2Phase 3 2Phase 4 1Phase 2/3 1Phase 1 1

Status

Unknown 2Completed 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Hemangioma, Capillary 2Hemangioma 2

Interventions

Cyclophosphamide 297Cisplatin 297Paclitaxel 258Radiotherapy 253Fluorouracil 234Carboplatin 234Docetaxel 231Doxorubicin 212Dexamethasone 164Gemcitabine 155Vincristine 143Etoposide 133Leucovorin 132Capecitabine 129Bevacizumab 129Prednisone 124Rituximab 118Methotrexate 117Cytarabine 108Filgrastim 99Trastuzumab 98Oxaliplatin 96pembrolizumab 81Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Nivolumab 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Completed × Propranolol × Clear all
NCT02342275 2022-06-16

Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma

West China Hospital

Phase 3 Completed
377 enrolled 13 charts

Hemangioma, Hemangioma, Capillary

NCT02505971 2020-10-28

Nadolol Versus Propranolol in Children With Infantile Hemangiomas

The Hospital for Sick Children

Phase 3 Completed
74 enrolled

Hemangioma, Hemangioma, Capillary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡